14 Apr by Vitaliy Dadalyan J&J eyes 'imminent' coronavirus vaccine production, aims for a billion doses worldwide Johnson & Johnson announced plans to begin 'at risk' production of its COVID-19 vaccine as it scales up for eventual testing and manufacture of the vaccine.
